J. Goldman & Co’s CervoMed CRVO Stock Holding History

J. Goldman & Co’s Portfolio CRVO Stock Details CRVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-16,707	Closed	-$244K	–	496
2024 Q3	$244K	Hold	16,707	–	–	0.01%	407
2024 Q2	$286K	Buy	16,707 +3,207	+24%	+$70.1K	0.01%	395
2024 Q1	$315K	Buy	+13,500	New	+$180K	0.01%	350

Other funds holding CRVO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

PWM

Perigon Wealth Management San Francisco, California $5.51B AUM 24.51% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

J. Goldman & Co's CRVO Position: Q4 2024 in Review

J. Goldman & Co sold out of CervoMed (CRVO) in Q4 2024, closing a stake of 16,707 shares — an estimated $244K sold.

J. Goldman & Co first reported a position in CRVO in Q1 2024 and held it in 3 quarters. The position peaked at $315K in Q1 2024. 49 funds tracked by Wall St. Rank hold CRVO as of Q4 2024.

J. Goldman & Co reported no remaining CervoMed position as of Q4 2024 after selling out during the quarter.
J. Goldman & Co sold 16,707 CervoMed shares in Q4 2024, an estimated $244K.
J. Goldman & Co first reported a position in CervoMed in Q1 2024 and held it in 3 quarters.
J. Goldman & Co's CervoMed position peaked at $315K in Q1 2024.
49 funds tracked by Wall St. Rank held CervoMed as of Q4 2024.

Based on J. Goldman & Co's 13F filing for Q4 2024, filed 14 Feb 2025.